Skip to main content

Table 4 Adverse events as percentage of subjects per group during the three treatment blocks

From: Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects

  Iscucin®Populi Viscum Mali e planta tota Placebo
  (n = 30) (n = 21) (n = 20)
Description of AE 0.0125% 0.25% 5% 1:1000 1:100 1:50    
  strength strength strength D3 D2 2%    
  F G H       
  Week Week Week Week Week Week Week Week Week
  1-4 5-8 9-12 1-4 5-8 9-12 1-4 5-8 9-12
Abdominal pain (%) 0 3 3 0 0 0 0 0 0
Common cold (%) 27 17 17 38 14 10 15 15 25
Diarrhea (%) 0 3 0 0 0 0 0 0 0
Dizziness (%) 0 3 0 0 0 0 5 0 0
Fatigue (%) 0 0 3 0 0 0 0 0 0
Fever (%) 0 3 0 0 0 0 0 0 0
Headache (%) 13 0 3 14 5 10 5 10 10
Nausea (%) 0 3 3 0 0 0 0 0 0
Swollen lymph nodes (%) 0 3 7 0 0 0 0 0 0
Vomiting (%) 3 3 0 0 0 0 0 0 0
Weakness (%) 0 0 0 5 0 0 5 0 0